FDA Approves First Generic Drug for Control of Clinical Signs of Equine Cushing’s Disease

The U.S. Food and Drug Administration has approved Zygolide (pergolide tablets) for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) in horses. PPID is also known as Equine Cushing’s Disease, an endocrine condition affecting the pituitary gland of horses.